CCDC63 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
A fungal metabolite that disrupts the function of the Golgi apparatus. By inhibiting protein transport from the ER to the Golgi, Brefeldin A can lead to a decrease in the functional activity of CCDC63 if its proper localization is critical for function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that alters the pH and ion gradients in cellular compartments, particularly the Golgi. Monensin's disruption of Golgi function can indirectly inhibit CCDC63 if it relies on Golgi-mediated post-translational modifications for activity. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A microtubule-stabilizing agent that can disrupt cellular division. If CCDC63 is involved in cell cycle progression, paclitaxel's stabilization of microtubules can indirectly inhibit the protein's function by arresting cells in specific phases. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule-depolymerizing agent that can arrest cells in the M-phase. If CCDC63 function is associated with cell cycle regulation, nocodazole can lead to functional inhibition of CCDC63 by halting cell cycle progression. | ||||||
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $72.00 $297.00 | 4 | |
These inhibitors prevent the activation of CDKs. If CCDC63 activity is regulated by cell cycle checkpoints, CDK inhibitors can indirectly inhibit CCDC63 by preventing cell cycle progression. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
An Aurora kinase A inhibitor that disrupts chromosome alignment and segregation. If CCDC63 is involved in mitotic processes, MLN8237 can inhibit its function by disturbing proper chromosome segregation during mitosis. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
An Aurora kinase inhibitor that affects spindle checkpoint function. If CCDC63 has a role in spindle assembly or maintenance, ZM447439 can inhibit its function by disrupting these processes. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
A Plk1 inhibitor that can arrest cells in mitosis. If CCDC63's functional activity is linked to mitotic progression, BI 2536 can lead to its inhibition by arresting cells and preventing mitotic exit. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
An inhibitor of ribonucleotide reductase that leads to DNA replication stress. If CCDC63 is involved in DNA damage response or repair, hydroxyurea can indirectly inhibit its function by inducing replication stress and activating damage checkpoints. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
An inhibitor of non-muscle myosin II ATPase activity. If CCDC63 is involved in cellular motility or cytoskeletal rearrangements, blebbistatin's inhibition of myosin II can lead to functional inhibition of CCDC63. | ||||||